Article
Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.
PloS one - 10 Nov 2010
Tasaki Shinya, Nagasaki Masao, Kozuka-Hata Hiroko, Semba Kentaro, Gotoh Noriko, Hattori Seisuke, Inoue Jun-ichiro, Yamamoto Tadashi, Miyano Satoru, Sugano Sumio, Oyama Masaaki
Abstract excerpt
BACKGROUND: Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such mutation has not yet been completely understood at the s...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
